Korsana’s lead program uses a next-generation shuttling technology to improve delivery into the brain and lower the incidence of amyloid-related imaging abnormalities.

A new light-based imaging approach has produced an unprecedented chemical map of the Alzheimer’s brain. Rice University researchers have produced what they describe as the first full, label-free ...

Scientists have developed a model using a blood test to forecast when a person is likely to start having symptoms of ...

A new entrant in the race to shepherd antibodies for Alzheimer’s disease across the blood-brain barrier has emerged. | A new entrant in the race to shepherd antibodies for Alzheimer’s disease across ...

Researchers have identified two brain receptors that help the brain clear away amyloid beta, a hallmark of Alzheimer’s ...

Researchers at Niigata University have used advanced three-dimensional (3D) imaging to reveal how amyloid β (Aβ) deposits ...

By far the strongest genetic risk factor for Alzheimer’s disease is a variant of apolipoprotein E, or ApoE. People who carry ...

The data showed older people had less time from when elevated p-tau217 appeared until they began having symptoms compared to younger ones.

XingImaging has been selected as the Imaging Core Lab for the Alzheimer's Tau Platform (ATP)--a groundbreaking, multi-arm, randomized Phase II clinical trial designed to simultaneously investigate ...

Researchers used CAR T therapy to target beta amyloid plaques in Alzheimer’s disease. In mice, the modified immune cells ...